The future of nuclear medicine would appear to be the paradigm of personalized medicine — targeted radionuclide therapy to spare healthy tissue, and theranostic medicine, which pairs an imaging isotope with a therapeutic isotope to provide simultaneous, real-time dose delivery and verification, leading to drastic reductions in prescribed patient dose. Candidate isotopes to meet these needs...
The study of targeted porous nanoparticles as drug carriers is a growing field in cancer-therapy research. The porosity of the particle enables anticancer drugs to be loaded inside the particle and its surface can be modified to include tumour targeting properties. The nanoparticles are then injected into the blood stream and through the properties of the carrier nanoparticles the anticancer...
Particle therapy uses proton or $^{12}\mathrm{C}$ beams for the treatment of deep-seated solid tumours. Due to the features of energy deposition of charged particles a small amount of dose is released to the healthy tissue in the beam entrance region, while the maximum of the dose is released to the tumour at the end of the beam range, in the Bragg peak region. Dose deposition is dominated by...
In order to carry out work in the nuclear sector in a cost effective way, while keeping risks ALARA, it is necessary to perform calculations of dose rates in areas where workers will be present, and it is important to choose the right tool for each job. The dependence of this choice upon the type of radiation, material, and geometry is obvious. Of at least equal importance, however, are...
